BDD With UDCA Therapy After Laparoscopic Cholecystectomy

Summary

Prospective Study for the Effects of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycolic Acid Therapy on Liver Function and Quality of Life After Laparoscopic Cholecystectomy Primary endpoint: peak level of postoperative AST (aspartate transaminase) and postoperative ALT (alanine tansaminase) Secondary endpoint: postoperative GIQLI (Gastrointestinal Quality of Life index) score

Timeline

Start

2018-04-24

Primary completion

2019-11-30

Completion

2019-12-31

Drugs

Indications